Dentium USA
$63.0K 38 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Medela LLC
Medela LLC reported $63,124.47 across General Payments, Research, and Ownership to 190 physicians and teaching hospitals across 190 transactions.
- $63.1K Below-median payer
- All-tracks total
- 190 Above-median volume
- Transactions
- 190 Above-median reach
- Recipients
- +$56.8K
- General Payments vs PY2023
Medela LLC reported $63,124.47 across all CMS Open Payments tracks (General + Research + Ownership) to 190 physicians and teaching hospitals in Program Year 2024 - ranking #1289 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $63,124.47, averaging $332.23 per recipient.
Medela LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
11/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer medela-llc Medela LLC
$63.1K · #1289/1,925 · 0.0% industry · PY2024
- TOT $63.1K
- RANK #1289
- SHARE 0.0%
- TXN 190
- RCP 190
- CAT 5
- GEN $63.1K
- ΔGEN +$56.8K
- TOP1 10.1%
- PY 2024
Volume peers
Nearest volume peer: Dentium USA ($63.0K)
Medela LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Medela LLC's CMS-reported General Payments increased by $56.8K (+893.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MEDELA LLCPY2023: MEDELA LLCPY2024: MEDELA LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $6,355.99
- PY2024
- $63,124.47
What the Data Shows for Medela LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Medela LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Food and Beverage" leads the 5-category general-payment breakdown below at $15.1K (23.9% of General Payments, 165 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Medela LLC made 5 types of general payments. "Food and Beverage" is the largest category at $15.1K, 23.9% of General Payments.
Medela LLC reports 5 general-payment categories - the top three are Food and Beverage (23.9%), Compensation for Services Other Than Consulting (23.5%), and Travel and Lodging (21.6%). The remaining 2 categories make up 31.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Medela LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $15.1K | 165 | 23.9% |
| Compensation for Services Other Than Consulting | $14.8K | 7 | 23.5% |
| Travel and Lodging | $13.6K | 8 | 21.6% |
| Consulting Fee | $13.3K | 6 | 21.0% |
| Compensation for Faculty or Speaker (Medical Education) | $6.3K | 4 | 10.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $20,170.51 (32.0%) of $63,124.47 in this company's General Payments records across 155 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Medela LLC
The five named recipients with the highest reported General Payments from this company
- 1
Rebecca Hoban
$6,382.45 across 2 reported transactions
- 2
Maria Lennon
$3,987.35 across 3 reported transactions
- 3
Kevin Lobdell
$3,518.26 across 4 reported transactions
- 4
Jessica Brumley
$3,266.87 across 2 reported transactions
- 5
Taryn Edwards
$3,015.58 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Medela LLC's spend rank (#1289 of 1,925, bottom 33% by spend) and concentration rank (#1,385 of 1,838, bottom 25% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Biocon Biologics Inc : $26.5K total payments, HHI 391
- Phadia US Inc. : $290.0K total payments, HHI 390
- Sonendo Inc : $1.3M total payments, HHI 386
- Astellas Pharma Global Development : $662.0K total payments, HHI 386
- Breg, Inc : $959.96 total payments, HHI 385
- Impulse Dynamics (USA) Inc. : $1.3M total payments, HHI 385
- Medela LLC (this company) : $63.1K total payments, HHI 384
- Ovesco Endoscopy USA, Inc. : $61.0K total payments, HHI 384
- Augmedics Inc. : $233.7K total payments, HHI 383
- Daiichi Sankyo Inc. : $6.9M total payments, HHI 382
- Biocomposites Inc : $138.8K total payments, HHI 381
- Dental Health Products, Inc. : $7.5K total payments, HHI 380
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Medela LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Medela LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Medela LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Tonix Medicines, Inc.
$63.3K 1,107 recipients
Compare payment profiles
MIS Implants Technologies, Inc.
$62.9K 11 recipients
Compare payment profiles
Cardinal Health Inc
$62.6K 40 recipients
Compare payment profiles
Zambon USA Ltd.
$62.5K 99 recipients
Compare payment profiles
Carbofix Spine Inc
$62.5K 83 recipients
Compare payment profiles
Put this to use
Medela LLC ranks #1289 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Medela LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.